Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Isarna Therapeutics

Request full access

Develop selective TGF-β inhibitors to effectively treat ophthalmic diseases

Munich, GermanyFounded 1998Biotech & Life Sciences

About Isarna Therapeutics

Isarna Therapeutics is a biotechnology company specializing in the development of antisense therapies aimed at blocking the production of TGF Beta, a key mediator of fibrosis in the eye and other organs such as the liver and lung. The company operates in the biopharmaceutical market, focusing on innovative treatments for conditions like neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Isarna's business model revolves around advancing its pipeline of antisense molecules through clinical trials, with the goal of bringing these therapies to market. Revenue is generated through partnerships, licensing agreements, and potential future sales of approved therapies. The company serves patients suffering from fibrotic diseases and eye conditions, as well as the broader medical community engaged in treating these ailments.

Source: Dealroom company data

Isarna Therapeutics in the Munich ecosystem

Live from Dealroom

The Isarna Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • MIG Capital

Series B and later1 investor entered at this stage

  • Global Asset Fund
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇩🇪 Germany40%
🇨🇭 Switzerland40%
🇳🇱 Netherlands20%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Isarna Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Isarna Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.